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Abstract
Background & Aims—A limited number of genetic risk factors have been reported in primary
sclerosing cholangitis (PSC). To discover further genetic susceptibility factors for PSC, we
followed up on a second tier of single nucleotide polymorphisms (SNPs) from a genome-wide
association study (GWAS).
Methods—We analyzed 45 SNPs in 1221 PSC cases and 3508 controls. The association results
from the replication analysis and the original GWAS (715 PSC cases and 2962 controls) were
combined in a meta-analysis comprising 1936 PSC cases and 6470 controls. We performed an
analysis of bile microbial community composition in 39 PSC patients by 16S rRNA sequencing.
Results—Seventeen SNPs representing 12 distinct genetic loci achieved nominal significance
(Preplication<0.05) in the replication. The most robust novel association was detected at
chromosome 1p36 (rs3748816; Pcombined=2.1×10−8) where the MMEL1 and TNFRSF14 genes
represent potential disease genes. Eight additional novel loci showed suggestive evidence of
association (Prepl<0.05). FUT2 at chromosome 19q13 (rs602662; Pcomb=1.9×10−6, rs281377;
Pcomb = 2.1×10−6 and rs601338; Pcomb=2.7×10−6) is notable due to its implication in altered
susceptibility to infectious agents. We found that FUT2 secretor status and genotype defined by
rs601338 significantly influences biliary microbial community composition in PSC patients.
Conclusions—We identify multiple new PSC risk loci by extended analysis of a PSC GWAS.
FUT2 genotype needs to be taken into account when assessing the influence from microbiota on
biliary pathology in PSC.
Keywords
primary sclerosing cholangitis; genome-wide association study; single nucleotide polymorphism;
immunogenetics
Introduction
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown
etiology, characterized by progressive inflammation and fibrosis of the bile ducts leading to
liver cirrhosis in many cases [1]. An important clinical feature of PSC is the frequent
autoimmune manifestations in other organ systems, most commonly inflammatory bowel
disease (IBD), which is reported in 62–83% of PSC patients of Northern European decent
[1]. In addition, approximately 25% of PSC patients are affected by at least one autoimmune
disease outside the liver and colon [2], most commonly type 1 diabetes, thyroid disease,
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rheumatoid arthritis and psoriasis. Shared genetic susceptibility could potentially explain the
frequent occurrence of these immune-related co-morbidities in PSC.
The importance of genetic risk factors in PSC is demonstrated by heritability studies
estimating siblings of PSC patients to be 9–39 times more likely to develop PSC than the
general population [1]. The contribution of genetic variants in the HLA complex on
chromosome 6p21 to the risk of PSC is well established [1]. Previously, strong evidence for
associated risk factors outside of the HLA region has been reported at chromosome 3p21 in
MST1 and chromosome 2q13 near BCL2L11 [3]. In addition, suggestive PSC associations
have been reported at six additional loci harboring the likely susceptibility genes GPBAR1,
IL2RA, GPC5/GPC6, IL2/IL21, CARD9 and REL [3–6]. In the most recent PSC GWAS
[3], only the top 23 associated regions were selected for replication genotyping.
Replication attempts of promising, but lower ranked markers from GWAS have yielded
valuable findings in multiple other diseases, and have been particularly fruitful when
combined with a semi-hypothesis driven approach taking into consideration gene content
and potential biological relevance [7]. In an attempt to identify novel susceptibility loci in
PSC, we selected a second tier of promising associated markers from an available PSC
GWAS [3] for replication in an independent cohort.
Materials and Methods
Study Subjects
The discovery panel included a total of 715 PSC cases and 2962 healthy controls, with 332
PSC cases and 262 controls from Scandinavia, and 383 PSC cases and 2700 controls from
Germany [3]. The replication panel consisted of a total of 1221 PSC cases and 3508
controls, with 289 PSC cases and 820 controls from Scandinavia, 561 PSC patients and
2063 controls from Central Europe, and 371 PSC cases and 625 controls from the United
States (US). The recruitment of study subjects is described in detail in the Supplementary
Methods in the Supplementary Material.
Written informed consent was obtained from all study participants. The study conforms to
the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the South-
Eastern Norwegian Regional Ethics Committee (S-93178 and S-08872b).
Association Analysis of Genome-Wide Data
Genome-wide genotyping, imputation and quality control in the discovery panel are
described in the Supplementary Methods. Association analysis of the genotyped and
imputed SNPs in the discovery panel was performed using a logistic regression procedure
implemented in the R statistical package version 2.9.1 (http://www.r-project.org). The six
first principal components generated by the EIGENSTRAT software [8] after removal of
population outliers were included as covariates in the regression to correct for residual
population structure.
Selection of SNPs for Extended Replication
A total of 2,466,182 SNPs were included in the association analysis of the GWAS dataset.
All nominally associated SNPs (P-value<0.05) outside the HLA complex (defined as
position 25 to 35 million base pairs on chromosome 6p21) which had previously not been
subjected to replication genotyping, were considered potential candidates for replication. We
aimed to integrate a priori knowledge on disease mechanisms in PSC and genetic
susceptibility factors for related conditions and traits by implementing two SNP
prioritization strategies for replication genotyping.
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Strategy I—All non-HLA SNPs with a GWAS P-value (PGWAS)<0.05 (n=134,466) were
aligned with SNPs reported to be associated in immune-mediated and chronic inflammatory
diseases and relevant biochemical parameters as listed in the Catalog of Genome-Wide
Association Studies (http://www.genome.gov/26525384) (accessed 23.04.2010)
Supplementary Table 2 lists the phenotypes taken into consideration.
Strategy II—Genetic loci harboring SNPs with robust statistical evidence of association in
the GWAS (PGWAS<1.0 ×10−4) underwent literature-based assessment taking potential
pathogenetic mechanisms in PSC into account [1]. Before this assessment, the number of
candidate SNPs with a PGWAS<1.0 ×10−4 were reduced by applying a linkage
disequilibrium (LD) clumping threshold of r2=0.8 and distance=50kb in PLINK version 1.06
[9] using LD measurements from the HapMap project.
To further avoid redundant genotyping, the total number of SNPs selected with strategies I
and II were clumped using a LD clumping threshold of r2=0.8 and distance=2000kb in
PLINK version 1.06 [9]. In FUT2, two redundant coding SNPs (rs601338 and rs281377)
were purposely retained. In addition, a tag (rs4143332, r2=1.0, D′=1.0) for the most strongly
associated SNP (rs3134792) in HLA-B was included. If assay design was not possible for
the index SNPs from the clumping, SNPs identified to be in LD with the SNP in the
clumping procedure were used instead.
Association Analysis of Replication Data and Meta-analysis
Replication genotyping and quality control are described in in the Supplementary Methods.
Association analysis in the three replication panels was performed by the Cochran-Mantel-
Haenszel (CMH) test as implemented in the PLINK version 1.06 [9]. Along with the CMH
test a Breslow-Day (BD) test for heterogeneity of odds ratios was performed. Meta-analysis
of the summary statistics in the discovery and replication panels was performed using the
Meta-Analysis Tool for genome-wide association scans, METAL
(http://www.sph.umich.edu/csg/abecasis/Metal) (version released 2010-08-01) (see
Supplementary Methods for details).
To adjust for multiple testing in the replication a strict Bonferroni correction was applied
assuming independence between the 45 SNPs analyzed (Bonferroni-adjusted P-value
threshold at 0.05/45=0.0011).
Association Signal Plots, Linkage Disequilibrium Calculations and Pathway Analysis
Regional association plots were generated from the GWAS data using the LocusZoom
software (see Supplementary Methods) [10]. For all other LD calculations data from the
HapMap project and PLINK version 1.06 [9] were used. To examine the functional
relationship among genomic PSC risk regions, we performed a Gene Relationships Across
Implicated Loci (GRAIL) pathway analysis (http://www.broadinstitute.org/mpg/grail/) (see
Supplementary Methods).
Biliary FUT2 Phenotyping, FUT2 sequence alignment and Profiling of Biliary Microbiota
Composition
To demonstrate presence of FUT2 in the bile duct epithelium, immunostaining for the
α(1,2)fucose-specific lectin Ulex europaeus agglutinin-I was performed. The biliary FUT2
phenotyping is described in detail in the Supplementary Methods. Sequence alignment of
human FUT2 with a range of different species was performed to evaluate evolutionary
conservation (see figure legend to Supplementary Figure 2). A fragment of the 16S rRNA
gene spanning the V1 and V2 hypervariable regions was amplified from processed bile
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samples of PSC patients and sequenced using 454 GS-FLX Titanium sequencing chemistry
as described [11] (see Supplementary Methods).
Results
SNP Selection and Genotyping Results
Seven hundred and fifteen PSC patients and 2962 controls were successfully genotyped and
analyzed in the GWAS (Table 1). Among the total of 2,466,182 genotyped and imputed
SNPs analyzed, a subset of 59 SNPs were selected for follow-up; 37 SNPs based on SNP
selection strategy I and 22 SNPs based on SNP selection strategy II. Following quality
pruning of the replication dataset a total of 45 SNPs were included in the association
analysis.
Association Results
A total of 17 SNPs achieved nominal significance in the replication (Prepl<0.05) and
demonstrated effect sizes in the same direction as observed in the discovery cohort (Table
2). Results for the additional 28 SNPs studied are provided in Supplementary Table 1. The
associated SNPs implicate 12 genetic loci, 9 of which had not previously been reported to be
associated with PSC. The association results for SNPs with nominally significant replication
with same direction of effect were homogenous (PHETEROGENEITY (HET)>0.05) when the
GWAS discovery and replication cohorts were compared, except for one marker
(rs11936230). Within the three panels constituting the replication cohort the significant
association results were also largely homogenous, however 2 markers (rs11682163 and
rs281377) had a significant Breslow-Day test implying heterogeneity of odds ratios
inbetween the three panels for these SNPs. Four SNPs at MMEL1/TNFRSF14, IL2/IL21
and CARD9 demonstrated association results robust to correction for multiple testing using
Bonferroni’s method (P<0.0011) in the replication analysis (Table 2).
The strongest finding in the replication panel was the missense SNP rs3748816 (M[ATG]
→ T[ACG]) located in MMEL1, which achieved genome-wide significance [12] in the
combined analysis (Pcomb=2.1×10−8) (Table 2). The association signal at this locus (1p36)
encompasses MMEL1 and extends into the tumor necrosis factor receptor superfamily
member 14 (TNFRSF14) gene (Figure 1).
FUT2 associations and bile microbial community composition
Eight novel loci demonstrated suggestive evidence for association in the replication panel
(Prepl<0.05), but were not robust to correction for multiple testing (Table 2). Of these, three
SNPs in the Fucosyltransferase 2 gene (FUT2, see Table 2 and Figure 1) at 19q13 (a
synonymous SNP, rs281377 (Pcomb=2.1×10−6), a nonsense SNP, rs601338 (W(TGG)
→*(TAG)) (Pcomb=2.7×10−6) and a missense SNP, rs602662 (G(GGT)→S(AGT))
(Pcomb=1.9×10−6) are of particular interest given the associations between FUT2 genotype
and several infectious diseases. Strong LD between these SNPs (r2rs601338 vs. rs281377=0.84,
r2rs601338 vs. rs602662=0.76 and r2rs281377 vs. rs602662=0.57) implies that the putatively
functional allele(s) cannot be directly determined by the association analysis. The rs601338
polymorphism generates a premature stop codon (W143X) and a truncated, dysfunctional
FUT2 protein [13]. By immunostaining for the α(1,2)fucose-specific lectin Ulex europaeus
agglutinin-I (Figure 2), we show that this stop codon appears to have a profound effect on
expression of α(1,2)fucosylated glycans in bile duct epithelium. The rs602662
polymorphism results in an amino acid substitution (G247S) which may be detrimental to
FUT2 function as shown by strong evolutionary conservation of this residue (Supplementary
Figure 2).
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To evaluate a potential functional role of FUT2 secretor status and genotype as defined by
rs601338 in the pathophysiology of PSC, we analyzed the bacterial community composition
of bile samples from 39 PSC patients (8 homozygous for the functional allele “G”, 21
heterozygous and 10 homozygous for the loss-of-function allele “A” (W(TGG)→*(TAG)),
since we previously observed genotype-dependent changes in community structure of the
colon in the context of Crohn’s disease [11]. Intriguingly, the abundances of several phyla
displayed significant differences with respect to FUT2 genotype and secretor status similar
to those observed in the colon. In particular, the Firmicutes are significantly elevated and
Proteobacteria significantly decreased among nonsecretors, in addition to differences
observed in the Bacteroidetes, Actinobacteria and Tenericutes (Figure 3A and
Supplementary Table 3). Similarly, alpha diversity measures display significant differences
with respect to genotype in the same manner observed in the colon, i.e. a decrease of
diversity in the heterozygous state compared to both homozygous genotypes (Figure 3B and
3C and Supplementary Table 4). Finally, differences in inter-individual variability, i.e. beta
diversity, are also apparent (adonis: unweighted UniFrac-r2=0.074, P=0.055 (genotype);
normalized weighted UniFrac- r2=0.057, P=0.049 (secretor status)) (Supplementary Figure
4A and 4B). Using the full species assemblage to test for differentiation with respect to
FUT2 genotype also revealed marginal results (Redundancy Analysis: F=1.140, P=0.085
(Supplementary Figure 4C)).
Additional suggestive associations
Among the other associated SNPs, rs2903692 (Pcomb=6.4×10−6) is located in the gene C-
type lectin domain family 16, member A (CLEC16A, see Table 2 and Figure 1). Two SNPs,
rs11203203 (Pcomb=2.9×10−5) and rs9976767 (Pcomb=4.0×10−4) localize to an intron of
ubiquitin associated and SH3 domain containing A gene (UBASH3A, see Table 2) and are
in LD (r2=0.63). The rs11682163 SNP (Pcomb=7.6×10−6) is localized in allantoicase (ALLC,
see Table 2) at 2p25. At 22q13, rs5771069 (Pcomb=5.8×10−4) is a missense SNP (L(CTT)
→P(CCT)) in interleukin 17 receptor E-like (IL17REL, see Table 2). At 12p12, the
rs4149056 SNP (Pcomb=0.0045) is a missense SNP (V(GTG)→A(GCG) in an exon of the
solute carrier organic anion transporter family gene (SLCO1B1). The rs4820599 SNP
(Pcomb=0.0038) is localized in an intron of the gamma-glutamyltransferase 1 gene (GGT1)
at 22q11. The rs3184504 SNP (Pcomb=4.6×10−4) represents a missense mutation (W(TGG)
→R(CGG) in an exon of the SH2B adaptor protein 3 gene (SH2B3, see Table 2) at 12q24.
The associated SNPs at 4q27 (rs13132245; Pcomb=1.2×10−7 and rs13119723;
Pcomb=9.9×10−8 ) are localized 42 kb upstream of and in an intron of KIAA1109,
respectively. Both rs13119723 and another genetic variant residing in this region,
rs6822844, which is in LD with the replicated SNPs at rs13132245 (r2 = 0.85) and
rs13119723 (r2 = 0.66) have been reported nominally associated with PSC in two candidate
gene studies [5, 6]. The replicated SNPs at 9q34 (rs4077515; Pcomb=7.6×10−5) in the
caspase-recruitment domain family, member 9 gene (CARD9) and at 2p16 (rs13017599;
Pcomb=1.9 ×10−4) near v-rel reticuloendotheliosis viral oncogene (REL) (Table 2 and
Supplementary Figure 1) also belong to loci which previously have been reported nominally
associated with PSC [5]. A GRAIL analysis of previously published and hereby detected
PSC risk loci demonstrated that several of the loci are functionally related (see
Supplementary Figure 3A and 3B).
Discussion
In the largest PSC cohort presented, we performed replication genotyping and a combined
analysis of 45 SNPs not followed up in a previous GWAS in PSC [3]. We identified one
novel PSC risk locus with association results below the threshold for genome-wide
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significance along with suggestive evidence for replication of 8 additional loci. The PSC
associated FUT2 variant was shown to significantly influence the bile microbial community
composition in PSC patients.
The replicated SNP at 1p36 (MMEL1-TNFRSF14) represents the first genetic overlap
demonstrated between PSC and primary biliary cirrhosis (PBC) [14]. Interestingly, the SNP
demonstrates opposite effect sizes in PSC and PBC [14]. Considering the peak association
signal of the observed non-synonymous SNP at MMEL1 (Figure 1), the suggestive presence
of MMEL1 protein expression in bile duct cells and glandular cells of the gall bladder
(http://www.proteinatlas.org) and the fundamental role of other membrane metallo-
endopeptidase family members in processes of metabolism, MMEL1 has a relevant
candidate role at this locus. For PSC, TNFRSF14 is also an intriguing candidate. The
TNFRSF14 protein is expressed on T-lymphocytes and mucosal epithelium and acts as a
receptor for the proinflammatory cytokine LIGHT [15]. TNFRSF14 signaling also has
inhibitory effects on B- and T-cells, and this dual role is thought to regulate immune
tolerance [16]. Mice lacking Btla (Btla−/− mice), the mediator responsible for the inhibitory
actions of TFNRSF14, spontaneously develop an autoimmune, hepatitis-like disease
accompanied by severe bile duct epithelium inflammation with nuclear pleomorphism and
irregularity of duct outlines [17] paralleling features of histopathological liver biopsy
specimens in human PSC [18].
FUT2 encodes an enzyme (Galactoside 2-alpha-L-fucosyltransferase 2) involved in protein
glycosylation, including the ABH blood-antigen synthesis pathway [13]. Genetic variants
giving rise to a non-functional, truncated FUT2-enzyme result in an inability to synthesize
ABH-antigens on mucosal surfaces and in salivary glands, which is referred to as non-
secretor status [13]. FUT2-determined secretor status has been observed to affect
susceptibility to a number of infectious agents [19], possibly by altering the recognition and
binding of pathogen adhesins to their preferred carbohydrate receptors on mucosal surfaces
[20]. Homozygosity for the PSC associated nonsense variant rs601338 has been reported to
account for > 95% of the prevalence of non-secretor status in Caucasians [21]. The nonsense
SNP rs601338 is also an risk factor for Crohn disease [19]. Although the bile duct is an
environment distinct from the portions of the GI tract most frequently afflicted by Crohn’s
disease, we observe strikingly similar changes with respect to the abundance of major
bacterial phyla and the level and pattern of bacterial diversity compared to previous
observations in the colon [11]. Thus, these general patterns appear to be consistent between
different habitats throughout the GI tract, which may underlie the overlapping association of
FUT2 to different chronic inflammatory disorders. Importantly, based on the present data,
further enquiries into this topic need to take account of both biliary FUT2 expression and the
biliary microbiome in the contaminated bile ducts of these patients, as well as the potential
effects from rs602662 genotype on FUT2 function [22, 23].
Among the additional novel suggestive loci, the CLEC16A association was most robust.
CLEC16A has a predicted C-type lectin domain structure [24] and C-type lectins serve as
central players in the immune response by modulating toll receptor function [25]. A role for
toll-like receptor signaling in PSC pathogenesis has been suggested [26], but whether
CLEC16A is implicated can only be speculated. Like for CLEC16A, the suggestive
associations observed at SLCO1B1 and GGT might also involve immunological
mechanisms since SLCO1B1 and GGT are involved in the hepatic uptake and
interconvertion of the inflammatory mediator leukotriene C4, respectively [27, 28]. The
associations at SLCO1B1 and GGT can also reflect other roles of these genes as the PSC
associated variants have been shown to alter blood levels of bilirubin and gamma
glutamyltransferase, respectively, in previous GWAS [29, 30].
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The potential roles of the PSC associations at IL2/IL21 and REL/PUS10 that are
strengthened by the current study have previously been extensively reviewed [31]. In a
disease like PSC, in which no effective medical therapy is available, the IL2 and IL2RA
genetic findings could prove to be of unique translational value (e.g. an IL-2 monoclonal
antibody (Daclizumab/Zenapax) is under clinical trials in other conditions). Like for FUT2,
the associations observed at CARD9 point towards the interaction of host genetics and
microbiota. When stimulated by intracellular pathogens, CARD9 interacts with NOD2 and
induces cytokine production or activates the NF-KB pathway [32].
It has been established that susceptibility loci in related conditions are typically implicated
in several disorders [33]. What is increasingly evident, and strengthened by our, study is that
PSC belongs to the family of autoimmune diseases, and that the overlapping genes are not
restricted to IBD susceptibility genes (Table 3). For a rare disease, a clear understanding of
the overlap with other immune mediated diseases may provide therapeutic opportunities
otherwise not within scope. There is also a strong need to expand on the genetic
susceptibility to PSC in study populations recruited outside of Northern-Europe and the
United States.
In conclusion, we identify multiple PSC risk loci involved in regulating the immune
response and the present study demonstrates a considerable overlap in the genetic
susceptibility with other autoimmune diseases not restricted to IBD. The FUT2 association
potentially represents other components of the pathogenesis, and the significant influence
from FUT2 genotype on biliary microbial composition demonstrated by our study should be
taken into account when further investigating the influence of microbiota on biliary
pathology.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Regional association plots for MMEL1/TNFRSF14, CLEC16A and FUT2
The association results for both the genotyped and imputed SNPs are represented by the
−log10 P-value plotted against the genomic position. The index SNP is marked out with a
purple diamond while the colors of the remaining SNPs indicate the linkage disequilibrium
with the index SNP. The recombination rates were derived from the HapMap project and are
represented by the thin blue lines. The plots were generated using the LocusZoom software
[10].
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Figure 2. Biliary FUT2 Phenotyping
Lectin staining of the hilar liver biopsy specimens from PSC patients. Paraffin-embedded
sections from individuals with AA (non-secretor) and GG (secretor) variants of the FUT2
rs601338 SNP were used to evaluate the expression of α(1,2)fucosylated glycans in bile
duct epithelium. H antigen, detected with the α(1,2)fucose-specific lectin Ulex europaeus
agglutinin-I (UEA-I) (brown staining), is expressed on the apical surface of the biliary
epithelial layer of secretor variant, while it is absent on non-secretor epithelia (Original
magnification X400).
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Figure 3. Influence of FUT2 genotype on phyla abundances and alpha diversity
(A)
Mean abundances (± SE) of the major phyla with respect to genotype at the nonsense SNP
rs601338 (W(TGG)→*(TAG). (B) The Abundance based Coverage Estimator (ACE) as a
measure of the approximated species richness [35] (C) Alpha diversity measured as the sum
of the total branch length in each sample (i.e. Phylogenetic Diversity) [36]. All values are
based on the normalized dataset (2,000 reads per individual).
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